Saquinavir mesilate or mesylate

This classification denotes a protease inhibitor with the molecular formula C38H50N6O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UHB9Z3841A, chemically known as butanediamide, n(sup 1)-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1h)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3s-(2(1r*(r*),2s*),3.alpha.,4a.beta.,8a.beta.))-, monomethanesulfonate, but more generally known as saquinavir mesylate, which bears US NIH Compound Identifier 60787. European Medicines Agency schedules saquinavir mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10446MIG. Most nations, for tariff purposes, schedule saquinavir mesylate under HS 29334910. As of Q4 2014, SAQUINAVIR MESYLATE remains US FDA's Preferred Term for this commodity. Saquinavir mesylate bears US NLM identifiers UMLS ID C0286737 and NCI Concept Code C1602. SMILES: CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3CCCCC3)NC(=O)[C@H](CC(=O)N)NC(=O)C4CCC5CCCCC5N4)O.CS(=O)(=O)O.